Sign in to fuzzto save your conversations, follow your research and come back anytime.
GlaxoSmithKline Pharmaceuticals
SectorHealthcare
| Metric (₹ crore) | Q1 FY19 | Q2 FY19 | Q3 FY19 | Q4 FY19 | Q1 FY20 | Q2 FY20 | Q3 FY20 | Q4 FY20 | Q1 FY21 | Q2 FY21 | Q3 FY21 | Q4 FY21 | Q1 FY22 | Q2 FY22 | Q3 FY22 | Q4 FY22 | Q1 FY23 | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 735.65 | 816.31 | 825.35 | 750.81 | 787.97 | 882.02 | 778.59 | 775.8 | 648.59 | 879.32 | 791.87 | 744.43 | 718.37 | 934.11 | 815.92 | 809.63 | 745.1 | 916.87 | 802.3 | 787.45 | 761.66 | 956.99 | 805.26 | 929.8 | 814.65 | 1,010.77 | 949.42 | 974.37 | 805.17 | 979.94 | 1,041.26 | 995.3 | 938.44 |
| Expenses | 600.02 | 651.28 | 688.2 | 587.83 | 622.68 | 688.01 | 654.2 | 602.24 | 534.52 | 674.46 | 611.21 | 587.75 | 585.65 | 677.98 | 618.11 | 634.41 | 596.18 | 659.94 | 573.6 | 617.71 | 617.78 | 667.5 | 587.2 | 672.54 | 584.11 | 689.06 | 657.5 | 641.18 | 553.97 | 644.21 | 669.92 | 644.37 | 642.94 |
| EBITDA | 135.63 | 165.03 | 137.15 | 162.98 | 165.29 | 194.01 | 124.39 | 173.56 | 114.07 | 204.86 | 180.66 | 156.68 | 132.72 | 256.13 | 197.81 | 175.22 | 148.92 | 256.93 | 228.7 | 169.74 | 143.88 | 289.49 | 218.06 | 257.26 | 230.54 | 321.71 | 291.92 | 333.19 | 251.2 | 335.73 | 371.34 | 350.93 | 295.5 |
| Depreciation | 11.36 | 11.51 | 12.04 | 13.68 | 19.06 | 22.7 | 18.33 | 22.59 | 21.77 | 21.96 | 17.54 | 17.68 | 17.54 | 17.43 | 17.87 | 15.35 | 15.82 | 16.36 | 16.41 | 17.18 | 16.36 | 18.11 | 17.11 | 18.1 | 16.41 | 16.86 | 18.8 | 14.72 | 15.52 | 17.43 | 20.32 | 13.17 | 15.84 |
| EBIT | 124.27 | 153.52 | 125.11 | 149.3 | 146.23 | 171.31 | 106.06 | 150.97 | 92.3 | 182.9 | 163.12 | 139 | 115.18 | 238.7 | 179.94 | 159.87 | 133.1 | 240.57 | 212.29 | 152.56 | 127.52 | 271.38 | 200.95 | 239.16 | 214.13 | 304.85 | 273.12 | 318.47 | 235.68 | 318.3 | 351.02 | 337.76 | 279.66 |
| Interest | 0.2 | 0.22 | 0.05 | 0.08 | 0.93 | 0.92 | 2.98 | 1.51 | 1.08 | 0.88 | 0.94 | 0.63 | 0.79 | 0.35 | 0.58 | 0.28 | 0.68 | 0.39 | 0.09 | 0.65 | 0.28 | 0.43 | 0.32 | 0.77 | 0.37 | 0.27 | 0.09 | 0.58 | 0.42 | 0.51 | 1.19 | 0.61 | 0.97 |
| Profit Before Tax | 124.07 | 153.3 | 125.06 | 149.22 | 145.3 | 170.39 | 103.08 | 149.46 | 91.22 | 182.02 | 162.18 | 138.37 | 114.39 | 238.35 | 179.36 | 159.59 | 132.42 | 240.18 | 212.2 | 151.91 | 127.24 | 270.95 | 200.63 | 238.39 | 213.76 | 304.58 | 273.03 | 317.89 | 235.26 | 317.79 | 349.83 | 337.15 | 278.69 |
| Net Profit | 84.08 | 100.83 | 113.67 | 146.81 | 113.54 | 502.75 | -661.16 | 138.07 | 110.83 | 76.47 | 156.51 | 14.33 | 121.08 | 204.24 | 150.35 | 1,219.05 | 119.28 | 193.42 | 164.56 | 133.43 | 132.25 | 217.51 | 45.72 | 194.48 | 182.33 | 252.5 | 229.88 | 262.87 | 205.01 | 257.49 | 295.62 | 277.86 | 237.18 |
| EPS | 9.93 | 5.95 | 6.71 | 8.67 | 6.7 | 29.68 | -39.03 | 8.15 | 6.54 | 4.51 | 10.26 | 0.85 | 7.14 | 12.06 | 8.87 | 71.96 | 7.04 | 11.42 | 9.71 | 7.41 | 7.04 | 12.84 | 9.89 | 11.37 | 10.76 | 14.67 | 13.57 | 15.52 | 12.1 | 15.07 | 16.54 | 16.4 | 14 |
| Metric (₹ crore) | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 337.64 | 138.9 | 234.37 | 472.8 | 409.49 | 490.5 | 577.91 | 810.75 | 484.23 | 582.02 | 1,289.9 | 903.3 |
| Investing Cash Flow | 180.01 | 499.02 | 300.64 | -104.19 | -153.45 | -56.84 | 418.03 | -405.51 | 807.85 | 8.71 | -45.8 | 396.98 |
| Financing Cash Flow | -496.99 | -638.33 | -510.76 | -306.63 | -358.36 | -427.62 | -695.56 | -524.24 | -1,543.32 | -561.5 | -769.42 | -737.08 |
| Net Cash Flow | 20.66 | -0.42 | 24.24 | 61.98 | -102.32 | 6.04 | 300.38 | -119 | -251.24 | 29.23 | 474.68 | 563.2 |
| Metric (₹ crore) | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 1,828.98 | 2,183.25 | 2,006.86 | 2,057.33 | 2,139.83 | 1,820.6 | 1,478.26 | 2,662.96 | 1,741.27 | 1,777.64 | 1,951.31 | 2,267.42 |
| Total Liabilities | 1,386.69 | 871.64 | 996.98 | 1,890.15 | 1,771.48 | 1,314.94 | 1,636.39 | 1,970.32 | 1,585.31 | 1,778.98 | 2,156.75 | 2,056.45 |
| Total Assets | 3,215.67 | 3,054.89 | 3,003.84 | 3,947.48 | 3,911.31 | 3,135.54 | 3,114.65 | 4,633.28 | 3,326.58 | 3,556.62 | 4,108.07 | 4,323.87 |